(BMI) Badger Meter - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0565251081
Flow Meters, Water Meters, AMR Systems, Sensors, Software
Dividends
| Dividend Yield | 0.83% |
| Yield on Cost 5y | 1.82% |
| Yield CAGR 5y | 14.90% |
| Payout Consistency | 92.8% |
| Payout Ratio | 31.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.4% |
| Value at Risk 5%th | 46.2% |
| Relative Tail Risk | -7.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -30.99 |
| CAGR/Max DD | 0.49 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.343 |
| Beta | 0.903 |
| Beta Downside | 0.710 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.69% |
| Mean DD | 9.25% |
| Median DD | 6.46% |
Description: BMI Badger Meter November 04, 2025
Badger Meter Inc. (NYSE:BMI) designs, manufactures, and markets flow-measurement and control solutions for a global customer base, ranging from municipal water utilities to original equipment manufacturers (OEMs) in industrial and HVAC markets.
The product portfolio includes smart-metering hardware (ORION cellular and mobile-read endpoints), wireless radio modules, high-frequency pressure and leak-detection sensors, optical and electrochemical water-quality instruments, and the BEACON cloud-based software suite that delivers alerts, analytics, and consumer-engagement tools.
In fiscal 2023 the company generated approximately $1.1 billion in revenue, with an operating margin near 12 % and a backlog that grew roughly 8 % year-over-year, reflecting strong demand for digital water-utility upgrades.
Key sector drivers include rising U.S. and global water-infrastructure investment (the U.S. EPA estimates $300 billion in needed upgrades over the next decade), tightening regulations on water loss and quality, and accelerating adoption of IoT-enabled metering that promises operational cost savings for utilities.
For a deeper quantitative view of Badger Meter’s valuation and risk profile, you may find it worthwhile to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (138.8m TTM) > 0 and > 6% of Revenue (6% = 54.1m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 0.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.86% (prev 49.78%; Δ -11.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 181.0m > Net Income 138.8m (YES >=105%, WARN >=100%) |
| Net Debt (-201.7m) to EBITDA (207.7m) ratio: -0.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.6m) change vs 12m ago 0.12% (target <= -2.0% for YES) |
| Gross Margin 41.26% (prev 39.55%; Δ 1.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.2% (prev 100.1%; Δ 1.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.28 (EBITDA TTM 207.7m / Interest Expense TTM -43.5m) >= 6 (WARN >= 3) |
Altman Z'' 7.98
| (A) 0.35 = (Total Current Assets 494.6m - Total Current Liabilities 153.4m) / Total Assets 978.3m |
| (B) 0.64 = Retained Earnings (Balance) 624.1m / Total Assets 978.3m |
| (C) 0.16 = EBIT TTM 142.7m / Avg Total Assets 890.6m |
| (D) 2.42 = Book Value of Equity 666.4m / Total Liabilities 275.8m |
| Total Rating: 7.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.52
| 1. Piotroski 6.0pt |
| 2. FCF Yield 3.21% |
| 3. FCF Margin 18.45% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -0.97 |
| 6. ROIC - WACC (= 6.72)% |
| 7. RoE 21.12% |
| 8. Rev. Trend 97.93% |
| 9. EPS Trend 96.01% |
What is the price of BMI shares?
As of December 06, 2025, the stock is trading at USD 180.14 with a total of 237,207 shares traded.
Over the past week, the price has changed by +0.90%, over one month by -3.02%, over three months by -1.24% and over the past year by -19.03%.
Over the past week, the price has changed by +0.90%, over one month by -3.02%, over three months by -1.24% and over the past year by -19.03%.
Is BMI a buy, sell or hold?
Badger Meter has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold BMI.
- Strong Buy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 219.5 | 21.8% |
| Analysts Target Price | 219.5 | 21.8% |
| ValueRay Target Price | 195.8 | 8.7% |
BMI Fundamental Data Overview November 27, 2025
Market Cap USD = 5.38b (5.38b USD * 1.0 USD.USD)
P/E Trailing = 37.8838
P/E Forward = 33.67
P/S = 5.9715
P/B = 7.4594
P/EG = 3.3648
Beta = 0.924
Revenue TTM = 901.1m USD
EBIT TTM = 142.7m USD
EBITDA TTM = 207.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 5.35m USD (from shortTermDebt, last fiscal year)
Debt = 6.01m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -201.7m USD (from netDebt column, last quarter)
Enterprise Value = 5.19b USD (5.38b + Debt 6.01m - CCE 201.7m)
Interest Coverage Ratio = -3.28 (Ebit TTM 142.7m / Interest Expense TTM -43.5m)
FCF Yield = 3.21% (FCF TTM 166.3m / Enterprise Value 5.19b)
FCF Margin = 18.45% (FCF TTM 166.3m / Revenue TTM 901.1m)
Net Margin = 15.40% (Net Income TTM 138.8m / Revenue TTM 901.1m)
Gross Margin = 41.26% ((Revenue TTM 901.1m - Cost of Revenue TTM 529.3m) / Revenue TTM)
Gross Margin QoQ = 40.67% (prev 41.08%)
Tobins Q-Ratio = 5.30 (Enterprise Value 5.19b / Total Assets 978.3m)
Interest Expense / Debt = 3.41% (Interest Expense 205.0k / Debt 6.01m)
Taxrate = 26.06% (12.4m / 47.4m)
NOPAT = 105.5m (EBIT 142.7m * (1 - 26.06%))
Current Ratio = 3.22 (Total Current Assets 494.6m / Total Current Liabilities 153.4m)
Debt / Equity = 0.01 (Debt 6.01m / totalStockholderEquity, last quarter 702.5m)
Debt / EBITDA = -0.97 (Net Debt -201.7m / EBITDA 207.7m)
Debt / FCF = -1.21 (Net Debt -201.7m / FCF TTM 166.3m)
Total Stockholder Equity = 657.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.19% (Net Income 138.8m / Total Assets 978.3m)
RoE = 21.12% (Net Income TTM 138.8m / Total Stockholder Equity 657.0m)
RoCE = 17.29% (EBIT 142.7m / Capital Employed (Total Assets 978.3m - Current Liab 153.4m))
RoIC = 16.05% (NOPAT 105.5m / Invested Capital 657.0m)
WACC = 9.33% (E(5.38b)/V(5.39b) * Re(9.34%) + D(6.01m)/V(5.39b) * Rd(3.41%) * (1-Tc(0.26)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.19%
[DCF Debug] Terminal Value 77.34% ; FCFE base≈152.1m ; Y1≈187.6m ; Y5≈320.1m
Fair Price DCF = 146.0 (DCF Value 4.30b / Shares Outstanding 29.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 96.01 | EPS CAGR: 20.57% | SUE: 0.47 | # QB: 0
Revenue Correlation: 97.93 | Revenue CAGR: 15.84% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.33 | Chg30d=+0.032 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=5.43 | Chg30d=+0.054 | Revisions Net=+7 | Growth EPS=+12.7% | Growth Revenue=+8.3%
P/E Trailing = 37.8838
P/E Forward = 33.67
P/S = 5.9715
P/B = 7.4594
P/EG = 3.3648
Beta = 0.924
Revenue TTM = 901.1m USD
EBIT TTM = 142.7m USD
EBITDA TTM = 207.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 5.35m USD (from shortTermDebt, last fiscal year)
Debt = 6.01m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -201.7m USD (from netDebt column, last quarter)
Enterprise Value = 5.19b USD (5.38b + Debt 6.01m - CCE 201.7m)
Interest Coverage Ratio = -3.28 (Ebit TTM 142.7m / Interest Expense TTM -43.5m)
FCF Yield = 3.21% (FCF TTM 166.3m / Enterprise Value 5.19b)
FCF Margin = 18.45% (FCF TTM 166.3m / Revenue TTM 901.1m)
Net Margin = 15.40% (Net Income TTM 138.8m / Revenue TTM 901.1m)
Gross Margin = 41.26% ((Revenue TTM 901.1m - Cost of Revenue TTM 529.3m) / Revenue TTM)
Gross Margin QoQ = 40.67% (prev 41.08%)
Tobins Q-Ratio = 5.30 (Enterprise Value 5.19b / Total Assets 978.3m)
Interest Expense / Debt = 3.41% (Interest Expense 205.0k / Debt 6.01m)
Taxrate = 26.06% (12.4m / 47.4m)
NOPAT = 105.5m (EBIT 142.7m * (1 - 26.06%))
Current Ratio = 3.22 (Total Current Assets 494.6m / Total Current Liabilities 153.4m)
Debt / Equity = 0.01 (Debt 6.01m / totalStockholderEquity, last quarter 702.5m)
Debt / EBITDA = -0.97 (Net Debt -201.7m / EBITDA 207.7m)
Debt / FCF = -1.21 (Net Debt -201.7m / FCF TTM 166.3m)
Total Stockholder Equity = 657.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.19% (Net Income 138.8m / Total Assets 978.3m)
RoE = 21.12% (Net Income TTM 138.8m / Total Stockholder Equity 657.0m)
RoCE = 17.29% (EBIT 142.7m / Capital Employed (Total Assets 978.3m - Current Liab 153.4m))
RoIC = 16.05% (NOPAT 105.5m / Invested Capital 657.0m)
WACC = 9.33% (E(5.38b)/V(5.39b) * Re(9.34%) + D(6.01m)/V(5.39b) * Rd(3.41%) * (1-Tc(0.26)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.19%
[DCF Debug] Terminal Value 77.34% ; FCFE base≈152.1m ; Y1≈187.6m ; Y5≈320.1m
Fair Price DCF = 146.0 (DCF Value 4.30b / Shares Outstanding 29.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 96.01 | EPS CAGR: 20.57% | SUE: 0.47 | # QB: 0
Revenue Correlation: 97.93 | Revenue CAGR: 15.84% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.33 | Chg30d=+0.032 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=5.43 | Chg30d=+0.054 | Revisions Net=+7 | Growth EPS=+12.7% | Growth Revenue=+8.3%
Additional Sources for BMI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle